A Two-Part, Single-Centre, Open (Part A) Single Blind (Part B), Randomised, Placebo-Controlled Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Doses With and Without Food and Multiple Ascending Oral Doses of AZD1305 Extended-Release Tablet in Healthy and Elderly Subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2010
At a glance
- Drugs AZD 1305 (Primary)
- Indications Arrhythmias
- Focus Adverse reactions
- 02 Dec 2010 Actual end date changed from Aug 2008 to Jul 2008 as reported by ClinicalTrials.gov.
- 17 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2008 New trial record.